Nuveen’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.41M | Buy |
201,949
+1,253
| +0.6% | +$34.2K | ﹤0.01% | 1786 |
|
|
2025
Q4 | $5.45M | Sell |
200,696
-48,499
| -19% | -$1.28M | ﹤0.01% | 1876 |
|
|
2025
Q3 | $6.45M | Sell |
249,195
-16,360
| -6% | -$379K | ﹤0.01% | 1785 |
|
|
2025
Q2 | $5.4M | Sell |
265,555
-163,571
| -38% | -$3.18M | ﹤0.01% | 1838 |
|
|
2025
Q1 | $7.79M | Buy |
429,126
+140,748
| +49% | +$3.14M | ﹤0.01% | 1696 |
|
|
2024
Q4 | $7.29M | Sell |
288,378
-75,257
| -21% | -$2.04M | ﹤0.01% | 1778 |
|
|
2024
Q3 | $12.4M | Sell |
363,635
-68,245
| -16% | -$2.6M | ﹤0.01% | 1479 |
|
|
2024
Q2 | $16M | Buy |
431,880
+62,797
| +17% | +$2.37M | ﹤0.01% | 1281 |
|
|
2024
Q1 | $15.5M | Buy |
369,083
+247,888
| +205% | +$10.2M | ﹤0.01% | 1328 |
|
|
2023
Q4 | $4.81M | Buy |
121,195
+915
| +0.8% | +$26.9K | ﹤0.01% | 2003 |
|
|
2023
Q3 | $3.31M | Sell |
120,280
-688
| -0.6% | -$21.6K | ﹤0.01% | 2068 |
|
|
2023
Q2 | $4.1M | Buy |
120,968
+420
| +0.3% | +$14.2K | ﹤0.01% | 2019 |
|
|
2023
Q1 | $4.34M | Sell |
120,548
-9,862
| -8% | -$426K | ﹤0.01% | 1973 |
|
|
2022
Q4 | $5.81M | Sell |
130,410
-19,236
| -13% | -$687K | ﹤0.01% | 1826 |
|
|
2022
Q3 | $4.21M | Sell |
149,646
-4,324
| -3% | -$133K | ﹤0.01% | 2002 |
|
|
2022
Q2 | $4.15M | Buy |
153,970
+20,044
| +15% | +$582K | ﹤0.01% | 2065 |
|
|
2022
Q1 | $4.55M | Sell |
133,926
-3,433
| -2% | -$110K | ﹤0.01% | 2111 |
|
|
2021
Q4 | $4.99M | Sell |
137,359
-10,129
| -7% | -$441K | ﹤0.01% | 2114 |
|
|
2021
Q3 | $8.02M | Buy |
147,488
+5,457
| +4% | +$256K | ﹤0.01% | 1931 |
|
|
2021
Q2 | $4.75M | Buy |
+142,031
| New | +$3.9M | ﹤0.01% | 2275 |
|
|
2015
Q2 | – | Sell |
-506
| Closed | -$211K | – | 1605 |
|
|
2015
Q1 | $211K | Buy |
+506
| New | +$181K | ﹤0.01% | 1507 |
|
|
2014
Q2 | – | Sell |
-5,763
| Closed | -$1.53M | – | 1607 |
|
|
2014
Q1 | $1.53M | Sell |
5,763
-234
| -4% | -$89.6K | 0.01% | 927 |
|
|
2013
Q4 | $2.18M | Buy |
5,997
+419
| +8% | +$161K | 0.01% | 754 |
|
|
2013
Q3 | $2.96M | Buy |
+5,578
| New | +$1.91M | 0.02% | 653 |
|
Other funds holding CLDX
KCM
VCM
CC
EP